NCT01171534

Brief Summary

Fasciotomy wounds are rarely able to be closed at the time of index surgery. They often require multiple returns to surgery for closure, and occasionally require skin grafting (i.e. they are never completely closed). We are interested in seeing whether this device, which provides constant and gradual tension on the wound, may allow for rapid wound closure in a safe fashion, perhaps even precluding a return trip to surgery. Null hypothesis #1: The Dermaclose Wound Management System (Woundcare Technologies Inc, Chanhassen, Minnesota) will not result in closure of fasciotomy wounds more rapidly than standard vessel loop techniques. Null hypothesis #2: The Dermaclose Wound Management System will not reduce the number of return trips to the operating room for surgical procedures related to closure or skin grafting of fasciotomy wounds.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 28, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
10 months until next milestone

Results Posted

Study results publicly available

December 10, 2014

Completed
Last Updated

January 29, 2018

Status Verified

January 1, 2018

Enrollment Period

3.1 years

First QC Date

July 27, 2010

Results QC Date

September 8, 2014

Last Update Submit

January 3, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Performance of DermaClose System in Treatment of Fasciotomy Wounds

    Days to wound closure; number and types of procedures required for wound closure; infection requiring reoperation; wound dehiscence requiring reoperation

    One year

Secondary Outcomes (3)

  • Pain

    One Year

  • Quality of Life

    One Year

  • Cost-to-Benefit Ratio of DermaClose Versus Vessel Loop Fasciotomy Closure

    One year

Study Arms (2)

Vessel Loop fasciotomy closure

ACTIVE COMPARATOR

Fasciotomy closure using vessel loops and staples.

Device: Vessel loop

DermaClose fasciotomy closure

EXPERIMENTAL

Fasciotomy closure via DermaClose device

Device: DermaClose fasciotomy closure

Interventions

The DermaClose device provides continuous expanding of the skin around the wound until it has stretched enough to allow the skin edges to be sutured closed.

Also known as: Continuous External Tissue Expander
DermaClose fasciotomy closure

Vessel loops and staples for fasciotomy closure

Vessel Loop fasciotomy closure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years of age or older
  • Patients undergoing fasciotomy for decompression of compartment syndrome, evolving compartment syndrome, or prophylactically to prevent compartment syndrome

You may not qualify if:

  • Patient younger than 18 years of age
  • Patients with an active infection
  • Patients unable to comply with protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri Hospital and Clinics

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Conditions

Wounds and InjuriesCompartment Syndromes

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Gregory J. Della Rocca, MD, PhD, FACS
Organization
University of Missouri, Department of Orthopaedic Surgery

Study Officials

  • Gregory J Della Rocca, MD. PhD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Co-Director of Trauma Services, Department of Orthopaedic Surgery

Study Record Dates

First Submitted

July 27, 2010

First Posted

July 28, 2010

Study Start

July 1, 2010

Primary Completion

August 1, 2013

Study Completion

February 1, 2014

Last Updated

January 29, 2018

Results First Posted

December 10, 2014

Record last verified: 2018-01

Locations